Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy

Total Page:16

File Type:pdf, Size:1020Kb

Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy PATHOPHYSIOLOGY of the RENAL BIOPSY www.jasn.org Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy Charles E. Alpers and Jolanta Kowalewska Department of Pathology, University of Washington, Seattle, Washington ABSTRACT extracellular accumulation of haphaz- Fibrillary glomerulonephritis is a now widely recognized diagnostic entity, occur- ardly arranged fibrils measuring ap- ring in approximately 1% of native kidney biopsies in several large biopsy series proximately 16 nm in thickness. Podo- obtained from Western countries. The distinctive features are infiltration of glo- cyte foot processes were diffusely merular structures by randomly arranged fibrils similar in appearance but larger effaced. There was no evidence of than amyloid fibrils and the lack of staining with histochemical dyes typically fibrillary deposits in the tubular base- reactive with amyloid. It is widely but not universally recognized to be distinct from ment membranes or interstitium. The immunotactoid glomerulopathy, an entity characterized by glomerular deposits of diagnosis of fibrillary glomerulone- immunoglobulin with substructural organization as microtubules and with clinical phritis was established on the basis of associations with lymphoplasmacytic disorders. The pathophysiologic basis for the ultrastructural findings in conjunc- organization of the glomerular deposits as fibrils or microtubules in these entities tion with the negative Congo Red stain remains obscure. and typical histologic and immunohis- J Am Soc Nephrol 19: 34–37, 2008. doi: 10.1681/ASN.2007070757 tochemical features. FIBRILLARY CASE PRESENTATION remaining glomeruli revealed marked expansion of mesangial stalks and ir- GLOMERULONEPHRITIS The patient was a 48-yr-old man who regular thickening of capillary walls as Fibrillary glomerulonephritis is a morpho- had a history of hypertension, hyperlip- a result of infiltration and accumula- logically defined entity characterized by idemia, obesity, and chronic renal insuf- tion of silver negative and periodic ac- glomerular accumulations of nonbranch- ficiency and was referred for evaluation id-Schiff–positive acellular material ing, randomly arranged fibrils that are ul- of proteinuria. The patient’s history was (Figure 1). There was neither signifi- trastructurally indistinguishable from notable for a myocardial infarction 5 yr cant increase in mesangial cellularity amyloid fibrils but differ from amyloid by previously. nor basement membrane “spike” for- virtue of their larger size and lack of reac- Physical examination revealed an mation. There was a background of tivity with Congo Red and other reagents obese man with BP of 168/89 mmHg and patchy interstitial fibrosis and tubular that are histochemically reactive with amy- no other notable findings. Urinalysis re- atrophy and associated interstitial in- loid.1–4 As in our case, this diagnosis re- vealed 4ϩ protein and 2ϩ glucose and flammation. Arterial vessels showed quires electron microscopic identification rare red and white blood cells and no mild intimal sclerosis. Staining with of characteristic infiltrating fibrils within casts. A 24-h urine collection revealed 8 g the Congo Red reagent for amyloidosis glomerular structures. It has been identi- of protein. Other relevant laboratory was negative. fied in approximately 0.5 to 1.0% of native data included serum albumin of 2.8 mg/ Immunofluorescence microscopy dl, creatinine of 4.2 mg/dl, and total cho- demonstrated confluent mesangial and lesterol of 204 mg/dl. Liver function tests glomerular capillary wall staining for Published online ahead of print. Publication date were within normal limits. Serologic IgG (3ϩ) and ␬ and ␭ light chain (each available at www.jasn.org. tests for evidence of autoimmune disease trace). There was no significant stain- Correspondence: Dr. Charles E. Alpers, Depart- were not obtained. ing of the glomeruli for IgA, IgM, C3, ment of Pathology, University of Washington Med- ical Center, 1959 NE Pacific Street, Box 356100, A renal biopsy showed cortex con- C1q, fibrinogen, or albumin. Ultra- NE110, Seattle, WA 98195. Phone: 206-598-6400; taining 16 glomeruli, seven of which structural examination of two glomer- Fax: 206-598-3803; E-mail: [email protected] were completely sclerosed and three of uli revealed expansion of the mesangial Copyright © 2008 by the American Society of which were segmentally sclerosed. The stalks and capillary walls as a result of Nephrology 34 ISSN : 1046-6673/1901-34 J Am Soc Nephrol 19: 34–37, 2008 www.jasn.org PATHOPHYSIOLOGY of the RENAL BIOPSY gested that as many as 20% of cases may be accompanied by crescent for- mation,4,5 although this number is high in our experience and the crescents are rarely a dominant feature. Most often, the glomeruli are without prominent inflammatory cell infiltration. Essen- tial to the diagnosis, as already indi- cated, is the absence of reactivity with Figure 1. Fibrillary glomerulonephritis. (A) An involved glomerulus shows mesangial regions infiltrated and expanded by acellular material; some capillary walls are thickened Congo Red or other agents typically by infiltration of this material (PAS stain). (B) The same glomerulus stained with Jones used for the histochemical demonstra- methenamine silver demonstrates focal duplication of capillary basement membrane and tion of amyloid in tissues. Immunoflu- lack of prominent argyrophilia of the infiltrating fibrillar material, in contrast to the usual orescence findings most often reveal situation with mesangial matrix. Magnification, ϫ400. polyclonal deposits of immunoglobu- lin (Ig), typically IgG, and light chains, but a small percentage of these patients kidney biopsies in at least three large biopsy DIAGNOSIS OF FIBRILLARY have monoclonal or oligoclonal Ig dep- series reported to date.3–5 It is distinct from GLOMERULONEPHRITIS osition characterized by deposits of Ig other, much rarer processes involving dep- heavy-chain and one light-chain sub- osition of glomerular fibrils such as occur The histologic appearance of fibrillary class (e.g., ␬ light chain) but not the with fibronectin glomerulopathy and col- glomerulonephritis is somewhat hetero- other.1–3 When studied by IgG subclass lagenofibrotic glomerulopathy.6 geneous. Common histologic patterns typing sera, deposition of IgG4 and Clinically, fibrillary glomerulone- include those of a membranoprolifera- IgG1 predominates in fibrillary glo- phritis most often presents in middle- tive glomerulopathy, diffuse prolifera- merulonephritis, a finding of uncertain aged to older patients (mean age 55 to tive glomerulonephritis, mesangial pro- pathophysiologic significance.4,5 The 60 yr), although the age range is wide liferative glomerulopathy and a smaller characteristic ultrastructural finding is and this disease has rarely been re- number of cases in which the pattern and an amyloid-like process in which glo- ported in the pediatric population. Pa- distribution of the fibrillary deposits is merular structures are infiltrated by tients typically present with protein- similar to that of membranous nephrop- randomly arranged, nonbranching uria, 50% within nephrotic range. athy.5 In many cases, a pattern of infiltra- fibrils that typically measure 12 to 24 Hematuria and hypertension are also tion of glomerular structures by amor- nm in diameter, with measurements common presenting conditions (60 phous acellular material is the most most frequently being approximately and 77%, respectively, in some series).5 striking feature unaccompanied by 18 to 20 nm (Figure 2).1–4 This con- No clinical laboratory findings are spe- prominent cellular proliferation (Figure trasts with the usual fibril size in amy- cific for this condition; all of the usual 1). This material can be seen to infiltrate loid (typically reported as being be- serologies obtained for the workup of mesangial regions and peripheral capil- tween 8 and 15 nm, but with the most various forms of glomerulonephritis lary walls, although in rare cases there typical measurements being 8 to 12 are typically negative and/or normal; may be no detectable histologic alter- nm).2 Fibrils in fibrillary glomerulone- however, there was a report of several ations and the glomerular appearance phritis are often enmeshed in regions patients who had features of fibrillary may be indistinguishable from minimal- in which there is electron lucency. glomerulonephritis and concomitant change disease. Some studies have sug- Granular electron-dense deposits, sim- infection with hepatitis C virus.7 The outcome for patients with this disease is frequently poor. Progression to end-stage renal disease occurs in approx- imately half of the patients within several years of diagnosis.4,5 There are no known established therapeutic regimens for this disease, and no organized clinical trials have tested the efficacy of any proposed clinical approach.8 Several studies have Figure 2. Ultrastructural features of the fibrils of amyloid (A), fibrillary glomerulonephritis documented the recurrence of this dis- (B), and microtubules of immunotactoid glomerulopathy (C). The amyloid fibrils are ease in renal transplants, which in some randomly arranged and nonbranching. In fibrillary glomerulonephritis, the fibrils are cases has resulted in nephrotic syndrome morphologically indistinguishable from those of amyloid but thicker. Immunotactoid and/or allograft loss.1,8–10 glomerulopathy is characterized by microtubules that are hollow when viewed on end. J Am Soc Nephrol 19: 34–37, 2008 Fibrillary Glomerulonephritis
Recommended publications
  • This Thesis Has Been Submitted in Fulfilment of the Requirements for a Postgraduate Degree (E.G
    This thesis has been submitted in fulfilment of the requirements for a postgraduate degree (e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following terms and conditions of use: This work is protected by copyright and other intellectual property rights, which are retained by the thesis author, unless otherwise stated. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author. The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author. When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given. Endothelin‐1 antagonism in glomerulonephritis Elizabeth Louise Owen BSc. (Hons), MSc. A thesis submitted towards the degree of PhD The University of Edinburgh 2016 Declaration I declare that the work presented in this thesis is my own and has not previously been published or presented towards another higher degree except where clearly acknowledged as such in the text. ……………………………………… …………. Elizabeth Louise Owen Date Page | 2 Acknowledgements I would like to express my gratitude to my supervisor David Kluth for his support, guidance and efforts during my PhD; Bean, thankyou for your patience and input. Thankyou also to Jeremy Hughes and Simon Brown for your advice and input for the various aspects of labwork, presentations and general how to’s. Jason King, thanks for all your help in the lab, you were always my ‘go‐to‐guy’ for all things technical….and for your many cool pairs of trainers.
    [Show full text]
  • Glomerulonephritis Management in General Practice
    Renal disease • THEME Glomerulonephritis Management in general practice Nicole M Isbel MBBS, FRACP, is Consultant Nephrologist, Princess Alexandra lomerular disease remains an important cause Hospital, Brisbane, BACKGROUND Glomerulonephritis (GN) is an G and Senior Lecturer in important cause of both acute and chronic kidney of renal impairment (and is the commonest cause Medicine, University disease, however the diagnosis can be difficult of end stage kidney disease [ESKD] in Australia).1 of Queensland. nikky_ due to the variability of presenting features. Early diagnosis is essential as intervention can make [email protected] a significant impact on improving patient outcomes. OBJECTIVE This article aims to develop However, presentation can be variable – from indolent a structured approach to the investigation of patients with markers of kidney disease, and and asymptomatic to explosive with rapid loss of kidney promote the recognition of patients who need function. Pathology may be localised to the kidney or further assessment. Consideration is given to the part of a systemic illness. Therefore diagnosis involves importance of general measures required in the a systematic approach using a combination of clinical care of patients with GN. features, directed laboratory and radiological testing, DISCUSSION Glomerulonephritis is not an and in many (but not all) cases, a kidney biopsy to everyday presentation, however recognition establish the histological diagnosis. Management of and appropriate management is important to glomerulonephritis (GN) involves specific therapies prevent loss of kidney function. Disease specific directed at the underlying, often immunological cause treatment of GN may require specialist care, of the disease and more general strategies aimed at however much of the management involves delaying progression of kidney impairment.
    [Show full text]
  • Diffuse Proliferative Glomerulonephritis and Acute Renal Failure Associated with Acute Staphylococcal Osteomyelitis
    Diffuse Proliferative Glomerulonephritis and Acute Renal Failure Associated with Acute Staphylococcal Osteomyelitis MATTHEW D. GRIFFIN,* JOHANNES BJORNSSON,t and STEPHEN B. ERICKSON* *Department of Internal Medicine, Division of Nephrology, and tDepartment of Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota. Abstract. A 72-year-old man developed acute renal failure after peated surgical debridement. Spontaneous recovery of renal coronary bypass surgery that had been complicated by sternal function occurred after eradication of infection and final sur- osteomyelitis caused by the Staphylococcus aureus bacterium. gical wound repair. The relationship between acute bacterial Bacteremia and sepsis were not present. Renal biopsy demon- infections and glomerulonephritis and, in particular, the causal strated a florid, diffuse, proliferative glomerulonephritis with role of staphylococcal antigens in the pathogenesis of such glomerular immune complex deposition. Management in- lesions is discussed. (J Am Soc Nephrol 8: 1633-1639, 1997) cluded hemodialysis, prolonged antibiotic therapy, and re- Coagulase-positive staphylococcus (Staphylococcus aureus) is mg/dl]) and in the immediate postoperative period. Over the the most common causative organism in acute osteomyelitis following days, the patient’s serum creatinine concentration (1). Along with coagulase-negative staphylococcal species, it increased progressively, and hemodialysis was instituted on has also been implicated in the pathogenesis of immune com- day 23 after CABG. There was no past or family history of plex (IC)-mediated diffuse proliferative glomerulonephritis renal disease and no known drug allergies. Prior medical (DPGN) in a variety of infections. These include bacterial history had included degenerative disc disease, stable abdom- endocarditis, ventriculoatrial shunt infections, pneumonia, and inal aortic aneurysm, stable benign prostatic hyperplasia, and visceral abscesses with or without septicemia (2-6).
    [Show full text]
  • Solid Tumour and Glomerulopathy
    QJ Med 1996; 89:361-367 Solid tumour and glomerulopathy P. PAI, J.M. BONE, I. McDICKEN and CM. BELL From the Regional Renal Unit, Royal Liverpool University Hospital, Liverpool, UK Received 11 October 1995 and in revised form 31 January 1996 Downloaded from https://academic.oup.com/qjmed/article/89/5/361/1578010 by guest on 01 October 2021 Summary We retrospectively examined the prevalence of solid centic GN and one case of focal segmental GN. tumours in patients with glomerulonephritis (GN) Bronchogenic (6) and gastrointestinal carcinoma followed in our regional renal unit between 1977 (CA) (5) were the commonest tumours encountered. and 1994. We identified 17 cases of what was Other tumours included breast CA (1), renal cell thought to be solid-tumour-related glomerulo- CA (1), prostatic CA (1), an epithelial thymoma and nephritis. Tumours and GN were diagnosed together a leiomyosarcoma of the lung. All MGN and mesang- in six cases, and within a year of each other in ial proliferative GN cases developed nephrotic range another four. In addition, there were seven other proteinuria, whereas all patients with rapidly pro- cases with a weaker temporal relationship (median gressive crescentic GN presented with acute renal duration between GN and cancer diagnosis, two failure. Four cases had received immunosuppressive and a half years) but which nonetheless could be therapy prior to tumour diagnosis. We discuss the tumour-related. In total, there were seven membran- validity of each case as tumour-related glomerulo- ous GN, four mesangial proliferative GN, five cres- nephritis. Introduction Since the first clinicopathological study to present an University Hospital serves a population of 2 million association between cancer and nephrotic syndrome people in the Mersey region of the Northwest of (NS) was suggested by Lee et a\.? the subject of England.
    [Show full text]
  • Glomerulonephritis
    Adolesc Med 16 (2005) 67–85 Glomerulonephritis Keith K. Lau, MDa,b, Robert J. Wyatt, MD, MSa,b,* aDivision of Pediatric Nephrology, Department of Pediatrics, University of Tennessee Health Sciences Center, Room 301, WPT, 50 North Dunlap, Memphis, TN 38103, USA bChildren’s Foundation Research Center at the Le Bonheur Children’s Medical Center, Room 301, WPT, 50 North Dunlap, Memphis, TN 38103, USA Early diagnosis of glomerulonephritis (GN) in the adolescent is important in initiating appropriate treatment and controlling chronic glomerular injury that may eventually lead to end-stage renal disease (ESRD). The spectrum of GN in adolescents is more similar to that seen in young and middle-aged adults than to that observed in prepubertal children. In this article, the authors discuss the clinical features associated with GN and the diagnostic evaluation required to determine the specific type of GN. With the exception of hereditary nephritis (Alport’s disease), virtually all types of GN are immunologically mediated with glomerular deposition of immunoglobulins and complement proteins. The inflammatory events leading to GN may be triggered by a number of factors. Most commonly, immune complexes deposit in the glomeruli or are formed in situ with the antigen as a structural component of the glomerulus. The immune complexes then initiate the production of proinflammatory mediators, such as complement proteins and cytokines. Subsequently, the processes of sclerosis within the glomeruli and fibrosis in the tubulointerstitial cells lead to chronic or even irreversible renal injury [1]. Less commonly, these processes occur without involvement of immune complexes—so-called ‘‘pauci-immune GN.’’ * Corresponding author.
    [Show full text]
  • Nephritis Fact Sheet
    Last Reviewed March 2017 Page 1 Prevent, Detect, Support. Fact sheet Nephritis How do the kidneys work? The kidneys are two large bean-shaped organs located in your lower back. Each kidney contains up to one million nephrons, the filtering units of your kidneys. Inside a nephron, there is a tiny set of blood vessels called the glomerulus. The glomerulus filters your blood allowing excess fluid and waste to be removed in your urine. What is nephritis? What causes nephritis? Nephritis (also called Most types of nephritis are caused by glomerulonephritis) is a group of your body’s immune system reacting diseases that cause inflammation to an ‘insult’ of some sort. This might (swelling) of the nephrons. This can be a medication, poison, infection reduce your kidney’s ability to filter or a change in the way your immune waste from your blood. system behaves. Your immune system makes antibodies to attack bacteria or poisons. These antibodies can damage your kidneys and nephrons, causing swelling and scarring. Connect with us www.kidney.org.au Freecall 1800 454 363 Kidney Health Australia Nephritis Last Reviewed March 2017 Prevent, Detect, Support. Page 2 What are the different types of nephritis? There are many different types of Different types of nephritis include: Nephrotic syndrome: Damage to the nephritis. It can vary from a mild, nephrons causes them to leak large Focal nephritis: Less than a half of non-damaging condition to a serious amounts of protein into your urine your nephrons have scarring, and problem causing kidney failure. Some but little blood. Losing this protein blood and a small amount of protein types of nephritis appear mild at means your body does not have are found in your urine.
    [Show full text]
  • Minimal Change Glomerulonephritis (GN)
    Patient information – Minimal Change Glomerulonephritis Minimal Change Glomerulonephritis (GN) What is it? Your kidney biopsy has shown that your swelling and protein leak (nephrotic syndrome) is caused by a condition called ‘Minimal Change Glomerulonephritis’. This is an inflammation in the glomeruli (the network of blood capillaries) of the kidney, which shows very little change looking down the ordinary microscope. More specialised tests (such as electron microscopy) on the biopsy show characteristic changes to make this diagnosis. It is the commonest cause of nephrotic syndrome in children and causes about a quarter of those in adults. While the symptoms can be quite unpleasant, it does not cause long- term damage to the kidney function. While many types of nephrotic syndrome cannot be treated, Minimal Change GN will respond to steroid treatment. Initial treatment This stops the protein leak in 94 –100% of cases. The main treatment is high dose Prednisolone (steroids) tablets for up to 16 weeks (although usually less time). You will be seen every two weeks, and once the urine is clear of protein, the dose will be gradually reduced over the following six months. Prednisolone 1mg/kg of body weight (max 80mg) daily Lansoprazole 30mg daily Alendronate 70mg weekly Nystatin 1ml four times a day Septrin 480mg daily As steroids may have many side effects, you will also be given additional medication to protect you from some of the more serious ones. Some possible side effects of the steroids · Infection: Steroids make you more prone to ‘opportunist infection’ (so-called, because they only affect vulnerable people). You will be given antibiotics (Septrin and Fluconazole), to protect against thrush and pneumonia.
    [Show full text]
  • Characterization of Iga Deposition in the Kidney of Patients with Iga Nephropathy and Minimal Change Disease
    Journal of Clinical Medicine Article Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease Won-Hee Cho 1, Seon-Hwa Park 2, Seul-Ki Choi 2, Su Woong Jung 2, Kyung Hwan Jeong 3, Yang-Gyun Kim 2 , Ju-Young Moon 2, Sung-Jig Lim 4 , Ji-Youn Sung 5, Jong Hyun Jhee 6, Ho Jun Chin 7,8, Bum Soon Choi 9 and Sang-Ho Lee 2,* 1 Department of Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea; [email protected] 2 Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea; [email protected] (S.-H.P.); [email protected] (S.-K.C.); [email protected] (S.W.J.); [email protected] (Y.-G.K.); [email protected] (J.-Y.M.) 3 Division of Nephrology, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul 02447, Korea; [email protected] 4 Department of Pathology, Kyung Hee University Hospital at Gangdong, Kyung Hee University, Seoul 05278, Korea; [email protected] 5 Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul 02447, Korea; [email protected] 6 Division of Nephrology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea; [email protected] 7 Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Korea; [email protected] 8 Department of Internal Medicine, College of Medicine, Seoul National University, Seoul 03080, Korea 9 Division of Nephrology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; [email protected] * Correspondence: [email protected] Received: 5 July 2020; Accepted: 9 August 2020; Published: 12 August 2020 Abstract: Approximately 5% of patients with IgA nephropathy (IgAN) exhibit mild mesangial lesions with acute onset nephrotic syndrome and diffuse foot process effacement representative of minimal change disease (MCD).
    [Show full text]
  • A Narrative Review on C3 Glomerulopathy: a Rare Renal Disease
    International Journal of Molecular Sciences Review A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease Francesco Paolo Schena 1,2,*, Pasquale Esposito 3 and Michele Rossini 1 1 Department of Emergency and Organ Transplantation, Renal Unit, University of Bari, 70124 Bari, Italy; [email protected] 2 Schena Foundation, European Center for the Study of Renal Diseases, 70010 Valenzano, Italy 3 Department of Internal Medicine, Division of Nephrology, Dialysis and Transplantation, University of Genoa and IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy; [email protected] * Correspondence: [email protected] Received: 5 December 2019; Accepted: 10 January 2020; Published: 14 January 2020 Abstract: In April 2012, a group of nephrologists organized a consensus conference in Cambridge (UK) on type II membranoproliferative glomerulonephritis and decided to use a new terminology, “C3 glomerulopathy” (C3 GP). Further knowledge on the complement system and on kidney biopsy contributed toward distinguishing this disease into three subgroups: dense deposit disease (DDD), C3 glomerulonephritis (C3 GN), and the CFHR5 nephropathy. The persistent presence of microhematuria with or without light or heavy proteinuria after an infection episode suggests the potential onset of C3 GP. These nephritides are characterized by abnormal activation of the complement alternative pathway, abnormal deposition of C3 in the glomeruli, and progression of renal damage to end-stage kidney disease. The diagnosis is based on studying the complement system, relative genetics, and kidney biopsies. The treatment gap derives from the absence of a robust understanding of their natural outcome. Therefore, a specific treatment for the different types of C3 GP has not been established.
    [Show full text]
  • Proteinuria and Nephrotic Syndrome
    Proteinuria and Nephrotic Syndrome Rebecca Hjorten, MD Division of Nephrology Speaker Disclosures • Relevant Financial Relationships: No disclosure. • Relevant Nonfinancial Relationships: No disclosure. • I have no actual or potential conflict of interest in relation to this program/presentation. Division of NephrologyDivision of Nephrology Urine Dip Concern for Positive for Urine Positive for Glomerulonephritis Protein Protein AND Blood (GN) …PIGN, MPGN, IgA, HSP Lupus, ANCA vasculitis, Urine Positive for Anti-GBM Asymptomatic Protein AND NORMAL Concerning Ex. Nephrotic Syndrome False Positive Symptoms Non-Significant Levels Persistent of Urine Protein Asymptomatic Consider Proteinuria Further Orthostatic Proteinuria Evaluation and Referral to Transient Proteinuria Pediatric Nephrology Division of Nephrology Urine Dip Concern for Positive for Urine Positive for Glomerulonephritis Protein Protein AND Blood (GN) …PIGN, MPGN, IgA, HSP Lupus, ANCA vasculitis, Urine Positive for Anti-GBM Asymptomatic Protein AND NORMAL Concerning Ex. Nephrotic Syndrome False Positive Symptoms Non-Significant Levels Persistent of Urine Protein Asymptomatic Consider Proteinuria Further Orthostatic Proteinuria Evaluation and Referral to Transient Proteinuria Pediatric Nephrology Division of Nephrology Objectives • Asymptomatic Proteinuria without Hematuria • Identification of transient and orthostatic proteinuria • Initial workup and referral or persistent proteinuria • Nephrotic syndrome • Early recognition of nephrotic syndrome • Initiation of management •
    [Show full text]
  • Pathologic Classification of Focal Segmental Glomerulosclerosis
    Pathologic Classification of Focal Segmental Glomerulosclerosis By Vivette D’Agati Focal segmental glomerulosclerosis (FSGS) is defined as a clinical-pathologic syndrome manifesting proteinuria and focal and segmental glomerular sclerosis with foot process effacement. The pathologic approach to the classification of FSGS is complicated by the existence of primary (idiopathic) forms and multiple subcategories with etiologic associations, including human immunodeficiency virus (HIV)-associated nephropathy, heroin ne- phropathy, familial forms, drug toxicities, and a large group of secondary FSGS mediated by structural-functional adaptations to glomerular hyperfiltration. A number of morphologic variants of primary and secondary focal sclerosis are now recognized, including FSGS not otherwise specified (NOS), perihilar, cellular, tip, and collapsing variants. The defining features of these morphologic variants and of the major subcategories of FSGS are discussed with emphasis on distinguishing light microscopic patterns and clinical-pathologic correlations. © 2003 Elsevier Inc. All rights reserved. HE FIRST IMAGE of focal segmental glo- tern of sclerosis evolves. Alterations of the podo- Tmerulosclerosis (FSGS) was published in cyte cytoarchitecture constitute the major ultra- 1925 in a remarkably accurate drawing by Fahr1 structural findings. from an atlas of human pathology. Even at that The approach to a diagnosis of FSGS is prob- early time, Fahr1 recognized the relatedness of this lematic because the morphologic features are non- novel lesion to minimal change disease when he specific and can occur in a variety of other condi- aptly entitled it lipoid nephrosis with degeneration. tions or superimposed on other glomerular It would be another 32 years before Rich2 provided processes.6 In addition, because the defining glo- a more detailed pathologic description of focal merular lesion is focal, it may not be adequately sclerosis in autopsy specimens of children dying sampled in small needle biopsies.
    [Show full text]
  • Anti-Factor B Antibodies and Acute Postinfectious GN in Children
    CLINICAL RESEARCH www.jasn.org Anti-Factor B Antibodies and Acute Postinfectious GN in Children Sophie Chauvet,1,2,3 Romain Berthaud,3,4 Magali Devriese,5 Morgane Mignotet,5 Paula Vieira Martins,5 Tania Robe-Rybkine,1 Maria A. Miteva,3,6 Aram Gyulkhandanyan,7 Amélie Ryckewaert,8 Ferielle Louillet,9 Elodie Merieau,10 Guillaume Mestrallet,11 Caroline Rousset-Rouvière,12 Eric Thervet,2,3 Julien Hogan,13 Tim Ulinski,14 Bruno O. Villoutreix,3,15 Lubka Roumenina,1 Olivia Boyer,3,4,16 and Véronique Frémeaux-Bacchi1,5,3 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background The pathophysiology of the leading cause of pediatric acute nephritis, acute postinfectious GN, including mechanisms of the pathognomonic transient complement activation, remains uncertain. It shares clinicopathologic features with C3 glomerulopathy, a complement-mediated glomerulopathy that, unlike acute postinfectious GN, has a poor prognosis. Methods This retrospective study investigated mechanisms of complement activation in 34 children with acute postinfectious GN and low C3 level at onset. We screened a panel of anticomplement protein autoantibodies, carried out related functional characterization, and compared results with those of 60 children from the National French Registry who had C3 glomerulopathy and persistent hypocomplementemia. Results All children with acute postinfectious GN had activation of the alternative pathway of the com- plement system. At onset, autoantibodies targeting factor B (a component of the alternative pathway C3 convertase) were found in a significantly higher proportion of children with the disorder versus children with hypocomplementemic C3 glomerulopathy (31 of 34 [91%] versus 4 of 28 [14%], respectively).
    [Show full text]